Becton, Dickinson and Co. | BDX - Loan Capital

Stock Price
206.51
Daily Change
-1.36 -0.65%
Monthly
0.56%
Yearly
-9.11%
Q1 Forecast
197.21

Becton, Dickinson and Co. reported $17.62B in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Abbott USD 11.6B 1.33B Sep/2025
Agilent USD 3.05B 300M Sep/2025
Align Technology USD 0 0 Dec/2024
Avanos Medical USD 93.4M 2.3M Sep/2025
Baxter International USD 9.49B 80M Jun/2025
Becton, Dickinson and Co. USD 17.62B 90M Sep/2025
Bio-Rad Laboratories USD 1.2B 300K Sep/2025
Boston Scientific USD 10.99B 12M Sep/2025
Cooper Companies USD 2.46B 26.1M Sep/2025
Danaher USD 18.42B 1.58B Dec/2025
Dentsply International USD 2.02B 201M Sep/2025
Dexcom USD 1.29B 55.6M Sep/2025
Edwards Lifesciences USD 598.2M 200K Sep/2025
Exact Sciences USD 2.33B 9.34M Sep/2025
Globus Medical USD 173K 84K Jun/2025
Hologic USD 2.5B 2.1M Dec/2025
Insulet USD 934.9M 4.1M Sep/2025
Integra LifeSciences USD 1.79B 565.41M Sep/2025
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 39.41B 173M Sep/2025
Masimo USD 559.1M 39.6M Sep/2025
Medtronic USD 26.18B 537M Jun/2025
Solventum Corp USD 5.14B 2.68B Sep/2025
Stryker USD 14.86B 14M Dec/2025
Tandem Diabetes Care USD 309.59M 444K Sep/2025
Teleflex USD 2.57B 769.86M Sep/2025
Terumo JPY 99.88B 13M Sep/2025
Thermo Fisher Scientific USD 35.85B 4B Dec/2025
Zimmer Biomet Holdings USD 7.51B 760.1M Sep/2025